Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-17-004264
Filing Date
2017-04-21
Accepted
2017-04-21 06:20:25
Documents
5
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 33714
2 image_001.jpg GRAPHIC 67815
3 image_002.jpg GRAPHIC 96305
4 image_003.jpg GRAPHIC 38106
5 image_004.jpg GRAPHIC 34151
  Complete submission text file 0001493152-17-004264.txt   360615
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37428 | Film No.: 17774165
SIC: 2834 Pharmaceutical Preparations